Coverage, interviews, and speaking appearances featuring Decima founder Mila Morris and the science behind our protocols. For press inquiries, contact us directly.
“Decima is built around one core belief: biology can be measured and improved. We specialize in advanced stem cell therapies with a focus on functional outcomes — stronger joints, improved cognition, tissue repair, measurable recovery markers. We are built around cellular performance.”
As told to Voyage Miami, February 2026
A long-form profile on Mila Morris and the founding of Decima — from a personal history with injury and the failures of conventional medicine, to building an internationally operating stem cell therapy platform focused on measurable biological outcomes and access to the most advanced cellular technologies available.
Read full interviewMila Morris featured in the official speaker lineup at Unfinished, an international ideas forum exploring transformative innovations at the intersection of science, technology, and human progress. Decima's approach to measurable longevity medicine and cell-based therapies presented to an international audience.
View speaker profileMila Morris speaks on longevity medicine, stem cell biology, the commercialization of regenerative medicine, and building transparent medical companies in a field often obscured by hype.
For interview requests, editorial coverage, expert commentary on regenerative medicine, or to discuss Decima for publication — contact us directly. We respond to all press inquiries within 24 hours.